Bruce & Co., Inc. Lava Therapeutics Nv Transaction History
Bruce & Co., Inc.
- $205 Million
- Q2 2024
A detailed history of Bruce & Co., Inc. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Bruce & Co., Inc. holds 771,874 shares of LVTX stock, worth $1.29 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
771,874
Previous 771,874
-0.0%
Holding current value
$1.29 Million
Previous $2.57 Million
45.95%
% of portfolio
0.68%
Previous 1.27%
Shares
3 transactions
Others Institutions Holding LVTX
# of Institutions
26Shares Held
3.76MCall Options Held
85.8KPut Options Held
36.8K-
Redmile Group, LLC San Francisco, CA2.07MShares$3.46 Million0.24% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3368KShares$613,8610.1% of portfolio
-
Two Sigma Investments, LP New York, NY112KShares$187,7730.0% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$145,9520.08% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il66.2KShares$110,6150.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $43.1M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...